Is There a Best Diuretic Drug for Heart Failure?
THURSDAY, Jan. 19, 2023 (HealthDay News) — It doesn’t matter which water pill you’re prescribed to treat your heart failure, because new trial data shows that one works as well as the other.Two diuretics widely used to treat heart failure, furosemide…
Learn MoreFrequent Green Space Visits Linked to Lower Use of Certain Meds
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — For individuals living in an urban environment, frequent green space visits are associated with less frequent use of psychotropic, antihypertensive, and asthma medications, according to a study published on…
Learn MoreLess Than a Third of Heavily Advertised Drugs Have ‘High Therapeutic Value’: Study
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — Television ads for drugs are filled with glowing images of people living their best lives, all thanks to that new med they’ve been prescribed.But drugs being touted on TV often have little to no benefit com…
Learn MoreApalutamide Safe for Men With Prostate Cancer on Active Surveillance
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — For men with low- to intermediate-risk prostate cancer on active surveillance, the negative repeat biopsy rate is high following 90 days of apalutamide, according to a study published in the February issue …
Learn MoreHerbal Remedies & You: 6 Tips to Safeguard Your Health
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — Not all prescription drugs and dietary herbal supplements work well together. It’s important to be aware of possible drug/supplement interactions that could be harmful, according to the U.S. National Center…
Learn MorePosoleucel Efficacious for Stem Cell Transplant Recipients
TUESDAY, Jan. 17, 2023 (HealthDay News) — For recipients of allogeneic hematopoietic cell transplantation (allo-HCT) with refractory viral infections/disease, the T-cell therapy posoleucel is well tolerated and effective, according to a study publish…
Learn MoreRisk for Hydroxychloroquine Retinopathy 8.6 Percent at 15 Years
TUESDAY, Jan. 17, 2023 (HealthDay News) — The overall risk for hydroxychloroquine retinopathy is 8.6 percent after 15 years, according to a study published online Jan. 17 in the Annals of Internal Medicine.Ronald B. Melles, M.D., from Kaiser Permanen…
Learn MoreLos negros y los hispanos con epilepsia con frecuencia no reciben los medicamentos más nuevos
JUEVES, 12 de enero de 2023 (HealthDay News) — Los adultos estadounidenses que sufren de epilepsia y que son negros o hispanos tienen menos probabilidades que los adultos blancos de que les receten los medicamentos más nuevos, según una investigación…
Learn MoreFluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
THURSDAY, Jan. 12, 2023 (HealthDay News) — For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a study published online Jan. 12 in Journal of the American Me…
Learn MoreBlack, Hispanic People With Epilepsy Often Miss Out on Latest Meds
THURSDAY, Jan. 12, 2023 (HealthDay News) — American adults who have epilepsy and are Black or Hispanic are less likely than white adults to be prescribed the latest medications, according to new research.“While finding the right medication is often a…
Learn More